Saha Samir K, Darmstadt Gary L, Baqui Abdullah H, Islam Nurul, Qazi Shamim, Islam Maksuda, El Arifeen Shams, Santosham Mathuram, Black Robert E, Crook Derrick W
Department of Microbiology, Dhaka Shishu Children Hospital, Dhaka, Bangladesh.
Pediatr Infect Dis J. 2008 Jan;27(1):49-53. doi: 10.1097/INF.0b013e31814d4e55.
Multidrug resistance (MDR), specifically to ampicillin and chloramphenicol, has complicated the treatment of Haemophilus influenzae type b (Hib) meningitis. This is worsened by use of prior antibiotics, which limits identification of the causative agent by culture and increases reliance on antigen detection.
We aimed to develop a PCR assay for detecting the family of Haemophilus integrating and conjugative elements (ICEs) represented by ICEHin1056 among antibiotic resistant Hib, and then apply this directly to CSF to diagnose Hib meningitis and predict organism susceptibility, irrespective of culture results.
Primers specific for orf 51 of ICEHin1056 were designed and multiplexed with Bex primers, specific for H. influenzae, and tested on culture positive and negative cases.
Of 73 Hib isolates, orf 51 PCR amplicons, predicting the presence of ICEs, were found in all 33 MDR isolates while only in 1 of 33 sensitive strains. The remaining 7 ampicillin susceptible, chloramphenicol and tetracycline resistant strains did not produce a PCR product to orf 51. PCR amplification from CSF specimens of these culture positive cases produced identical results with 100% and 97% positive and negative predictive values, respectively. Multiplex PCR to detect Bex and orf 51 identified another 16 MDR Hib cases among 81 culture-negative CSF samples.
Direct PCR for orf 51 in CSF identified resistance pattern of 51% more Hib strains than culture alone (110 versus 73). The ability to detect MDR, in culture negative Hib meningitis cases has significant implications for better directing antibiotic treatment of meningitis cases and thus for preventing disability and death.
多重耐药性,特别是对氨苄西林和氯霉素的耐药性,使b型流感嗜血杆菌(Hib)脑膜炎的治疗变得复杂。先前使用抗生素会使情况恶化,这限制了通过培养来鉴定病原体,并增加了对抗原检测的依赖。
我们旨在开发一种聚合酶链反应(PCR)检测方法,用于检测抗生素耐药性Hib中以ICEHin1056为代表的流感嗜血杆菌整合与接合元件(ICEs)家族,然后将其直接应用于脑脊液(CSF)以诊断Hib脑膜炎并预测病原体易感性,而无需考虑培养结果。
设计了针对ICEHin1056的orf 51的特异性引物,并与针对流感嗜血杆菌的Bex引物进行多重扩增,在培养阳性和阴性病例上进行测试。
在73株Hib分离株中,所有33株多重耐药分离株均检测到预测ICEs存在的orf 51 PCR扩增子,而33株敏感菌株中仅1株检测到。其余7株对氨苄西林敏感、对氯霉素和四环素耐药的菌株未产生orf 51的PCR产物。对这些培养阳性病例的脑脊液标本进行PCR扩增,结果相同,阳性和阴性预测值分别为100%和97%。在81份培养阴性的脑脊液样本中,通过多重PCR检测Bex和orf 51又鉴定出16例多重耐药Hib病例。
脑脊液中orf 51的直接PCR检测比单独培养多鉴定出51%的Hib菌株耐药模式(110株对73株)。在培养阴性的Hib脑膜炎病例中检测多重耐药性的能力对于更好地指导脑膜炎病例的抗生素治疗,从而预防残疾和死亡具有重要意义。